14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:RUBY
Delisted

Rubius Therapeutics Inc. Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0570
+0 (+0%)
At Close: Mar 28, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0570 $0.0570 Thursday, 28th Mar 2024 RUBY stock ended at $0.0570. During the day the stock fluctuated 0% from a day low at $0.0570 to a day high of $0.0570.
90 days $0.0550 $0.0570
52 weeks $0.0032 $0.115

Historical Rubius Therapeutics Inc. prices

Date Open High Low Close Volume
Mar 28, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 27, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 26, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 25, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 22, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 21, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 20, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 19, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 18, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 15, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 14, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 13, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 12, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 11, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 08, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 07, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 06, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 05, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 04, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Mar 01, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Feb 29, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Feb 28, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Feb 27, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Feb 26, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Feb 23, 2024 $0.0570 $0.0570 $0.0570 $0.0570 0
Click to get the best stock tips daily for free!

About Rubius Therapeutics Inc.

Rubius Therapeutics. Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 201... RUBY Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT